Homogeneity assessment for pivotal medical device clinical studies

被引:0
|
作者
Yan, Xu [1 ]
Ahn, Chul [1 ]
Chu, Jianxiong [1 ]
Dong, Li Ming [1 ]
Li, Heng [1 ]
Li, Xuefeng [1 ]
Lu, Hong [1 ]
Lu, Nelson [1 ]
Mukhi, Vandana [1 ]
Nair, Rajesh [1 ]
Tiwari, Ram [1 ]
Xu, Yunling [1 ]
Yue, Lilly Q. [1 ]
机构
[1] US FDA, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA
关键词
Medical device; homogeneity assessment; poolability; clinical study; PROPENSITY SCORE; SUBGROUP ANALYSIS; RISK DIFFERENCE; TRIALS; TESTS;
D O I
10.1080/10543406.2019.1657131
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A question that routinely arises in medical device clinical studies is the homogeneity across demographic subgroups, geographical regions, or investigational sites of the enrolled patients in terms of treatment effects or outcome variables. The main objective of this paper is to discuss statistical concepts and methods for the assessment of such homogeneity and to provide the practitioner a statistical framework and points to consider in conducting homogeneity assessment. Demographic subgroups, geographical regions, and investigational sites are discussed separately as each has its unique issues. Specific considerations are also given to randomized controlled trials, non-randomized comparative studies, and single-arm studies. We point out that judicious use of statistical methods, in conjunction with sound clinical judgment, is essential in handling the issue of homogeneity of treatment effect in medical device clinical studies.
引用
收藏
页码:749 / 759
页数:11
相关论文
共 50 条
  • [1] A pivotal medical-device case
    Curfman, Gregory D.
    Morrissey, Stephen
    Drazen, Jeffrey M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (01): : 76 - 77
  • [2] A pivotal medical-device case
    Picca, Stephen M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (16): : 1758 - 1758
  • [3] Statistical Considerations for Bias and Protocol Deviation in Medical Device Pivotal Clinical Study
    Xu, Zhiheng
    Li, Meijuan
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2019, 53 (05) : 623 - 629
  • [4] Medical Device Security Regulations and Assessment Case Studies
    Taylor, Kai
    Smith, Alexandra
    Zimmel, Adam
    Alcantara, Korina
    Wang, Yong
    2022 IEEE 19TH INTERNATIONAL CONFERENCE ON MOBILE AD HOC AND SMART SYSTEMS (MASS 2022), 2022, : 742 - 747
  • [5] Longitudinal data analysis in medical device clinical studies
    Lao, Chang S.
    Bushar, Harry F.
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2008, 18 (01) : 44 - 53
  • [6] Statistical and regulatory issues in nonrandomized medical device clinical studies
    Lilly, Heng Li
    Yue, Lilly Q.
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2008, 18 (01) : 20 - 30
  • [7] The cloudUPDRS app: A medical device for the clinical assessment of Parkinson's Disease
    Stamate, C.
    Magoulas, G. D.
    Kueppers, S.
    Nomikou, E.
    Daskalopoulos, I.
    Jha, A.
    Pons, J. S.
    Rothwell, J.
    Luchini, M. U.
    Moussouri, T.
    Iannone, M.
    Roussos, G.
    PERVASIVE AND MOBILE COMPUTING, 2018, 43 : 146 - 166
  • [8] Medical Professionalism as a Pivotal Goal in the Postgraduate Clinical Training
    Fukui, Tsuguya
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2024, 144 (06): : 591 - 598
  • [9] CLINICAL-STUDIES USED IN MEDICAL DEVICE APPROVALS - CAN THEY BE IMPROVED
    GLASGOLD, AI
    JOURNAL OF LONG-TERM EFFECTS OF MEDICAL IMPLANTS, 1993, 3 (03) : U161 - U163
  • [10] The FDA's role in medical device clinical studies of human subjects
    Saviola, James
    JOURNAL OF NEURAL ENGINEERING, 2005, 2 (01) : S1 - S4